# A Real-World Medical Chart Review of Spinal Muscular Atrophy Patients Treated With Onasemnogene Abeparvovec in Saudi Arabia

> **NCT07737756** · — · RECRUITING · sponsor: **Novartis Pharmaceuticals** · enrollment: 6 (estimated)

## Conditions studied

- Spinal Muscular Atrophy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07737756
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-25
- **Primary completion:** 2026-11-25
- **Final completion:** 2026-11-25
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07737756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07737756, "A Real-World Medical Chart Review of Spinal Muscular Atrophy Patients Treated With Onasemnogene Abeparvovec in Saudi Arabia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07737756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*